Ana Renic-Podolski

Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Tetramic Acid-Derived Blue-Emitting Fluorescent Probe for Selective Lipid Droplet Imaging in Live Cells and Zebrafish.

Tetramic Acid-Derived Blue-Emitting Fluorescent Probe for Selective Lipid Droplet Imaging in Live Cells and Zebrafish.

Journal: ChemMedChem

Published: April 30, 2026

Editorial: Combination therapies in cancer treatment: enhancing efficacy and reducing resistance.

Editorial: Combination therapies in cancer treatment: enhancing efficacy and reducing resistance.

Journal: Frontiers in pharmacology

Published: December 17, 2025

Novel Adamantane-Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma Cells.

Novel Adamantane-Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma Cells.

Journal: Molecules (Basel, Switzerland)

Published: November 21, 2025

Novel pyrimidine-artesunate hybrids overcome multidrug-resistance in non-small cell lung carcinoma through collateral sensitivity.

Novel pyrimidine-artesunate hybrids overcome multidrug-resistance in non-small cell lung carcinoma through collateral sensitivity.

Journal: Bioorganic chemistry

Published: October 07, 2025

PARP inhibition increases sensitivity to cisplatin in non-small-cell lung carcinoma via the induction of TET-dependent hydroxymethylation.

PARP inhibition increases sensitivity to cisplatin in non-small-cell lung carcinoma via the induction of TET-dependent hydroxymethylation.

Journal: Frontiers in cell and developmental biology

Published: July 31, 2025

Sclareol-based natural nanoparticles with adamantane moieties exert anticancer effects against non-small cell lung carcinoma cells.

Sclareol-based natural nanoparticles with adamantane moieties exert anticancer effects against non-small cell lung carcinoma cells.

Journal: Bioorganic chemistry

Published: July 06, 2025

Isorhamnetin Modulates Drug-Resistance-Related Biomarkers in Colon Cancer Cells.

Isorhamnetin Modulates Drug-Resistance-Related Biomarkers in Colon Cancer Cells.

Journal: International journal of molecular sciences

Published: May 27, 2025

Editorial on Special Issue: "Novel Therapeutic Strategies for Glioblastoma".

Editorial on Special Issue: "Novel Therapeutic Strategies for Glioblastoma".

Journal: Pharmaceutics

Published: May 05, 2025

Associating Patient Responses with Drug Sensitivity in Non-Small Cell Lung Carcinoma Using an Immunoassay on Patient-Derived Cell Cultures.

Associating Patient Responses with Drug Sensitivity in Non-Small Cell Lung Carcinoma Using an Immunoassay on Patient-Derived Cell Cultures.

Journal: Current issues in molecular biology

Published: March 07, 2025

LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models.

LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models.

Journal: Pharmaceutics

Published: December 12, 2024

Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine.

Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine.

Journal: Life (Basel, Switzerland)

Published: July 31, 2024

Plant-Based Products Originating from Serbia That Affect P-glycoprotein Activity.

Plant-Based Products Originating from Serbia That Affect P-glycoprotein Activity.

Journal: Molecules (Basel, Switzerland)

Published: July 23, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026